Prevalence of primary Helicobacter pylori resistance to several antimicrobials in a Saudi teaching hospital

被引:17
作者
Eltahawy, AT [1 ]
机构
[1] King Abdulaziz Univ Hosp, Microbiol Lab, Jeddah 21589, Saudi Arabia
关键词
Helicobacter pylori; primary resistance; metronidazole; clarithromycin; amoxycillin; tetracycline;
D O I
10.1159/000058009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the resistance rate of the most commonly used antimicrobial agents amongst Helicobacter pylori isolates. Methods: The agar disk diffusion method (Kirby Bauer) was utilized to determine the susceptibility of 223 H. pylori strains isolated before treatment. Isolates were tested against metronidazole (5 mug), clarithromycin (15 mug), amoxycillin (10 mug), and tetracycline (30 mug). Results: The resistance rate was 80% for metronidazole and 4% for clarithromycin. Tetracycline and amoxycillin showed very low degree of resistance with 1 (0.4%) and 3 (1.3%) of the strains resistant to these antibiotics, respectively. Age, sex and ethnicity had a remarkable effect on the resistance rate. Conclusion:The results indicate that metronidazole and clarithromycin should not be used as the only antimicrobial agents in the treatment of H. pylori infection. Susceptibility testing using the disk diffusion method is cost-effective in the screening of antimicrobial resistance against H. pylori. Copyright (C) 2002 S. Karger A G, Basel.
引用
收藏
页码:65 / 68
页数:4
相关论文
共 26 条
[1]   Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin -: Influence on treatment outcome [J].
Adamek, RJ ;
Suerbaum, S ;
Pfaffenbach, B ;
Opferkuch, W .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (03) :386-389
[2]  
BAZZOLI F, 1999, EUR J GASTROENTER S2, V11, P39
[3]   OMEPRAZOLE ENHANCES EFFICACY OF TRIPLE THERAPY IN ERADICATING HELICOBACTER-PYLORI [J].
BORODY, TJ ;
ANDREWS, P ;
FRACCHIA, G ;
BRANDL, S ;
SHORTIS, NP ;
BAE, H .
GUT, 1995, 37 (04) :477-481
[4]   cagA status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia [J].
Broutet, N ;
Marais, A ;
Lamouliatte, H ;
De Mascarel, A ;
Samoyeau, R ;
Salamon, R ;
Mégraud, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) :1319-1322
[5]   Helicobacter pylori treatment and antibiotic susceptibility:: results of a five-year audit [J].
Fraser, AG ;
Moore, L ;
Hackett, M ;
Hollis, B .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1999, 29 (04) :512-516
[6]   Antibiotic resistance in Helicobacter pylori:: Implications for therapy [J].
Graham, DY .
GASTROENTEROLOGY, 1998, 115 (05) :1272-1277
[7]   Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer [J].
Labenz, J ;
Tillenburg, B ;
Weismuller, J ;
Lutke, A ;
Stolte, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (01) :95-100
[8]   The MACH2 study:: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies [J].
Lind, T ;
Mégraud, F ;
Unge, P ;
Bayerdörffer, E ;
O'Morain, C ;
Spiller, R ;
van Zanten, SV ;
Bardhan, KD ;
Hellblom, M ;
Wrangstadh, M ;
Zeijlon, L ;
Cederberg, C .
GASTROENTEROLOGY, 1999, 116 (02) :248-253
[9]   Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori [J].
Mégraud, F .
GASTROENTEROLOGY, 1998, 115 (05) :1278-1282
[10]  
MEGRAUD F, 1995, EUR J GASTR HEPAT S1, V7, P49